Discontinued — last reported Q1 '17
Investment Proceeds
InvestingEli Lilly Investment Proceeds decreased by 76.3% to $132.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 137.4%, from $55.60M to $132.00M. Over 4 years (FY 2021 to FY 2025), Investment Proceeds shows an upward trend with a 112.4% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ1 2007
Last reportedQ1 2017
How to read this metric
An increase indicates the company is liquidating its investment portfolio, potentially to fund large capital projects, acquisitions, or dividends.
Detailed definition
The cash received from the sale or maturity of investment securities, including government bonds and corporate debt. Thi...
Peer comparison
This metric is often analyzed alongside 'Purchases of Investments' to determine the net movement in a company's 'cash pile'.
Metric ID:
cf_proceeds_from_investmentsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $17.30M | $25.30M | $800.00K | $26.70M | $30.90M | $25.50M | $38.30M | $281.90M | $106.50M | $87.80M | $31.90M | $70.50M | $179.60M | $67.90M | $55.60M | $71.60M | $204.30M | $556.10M | $132.00M |
| QoQ Change | — | +46.2% | -96.8% | >999% | +15.7% | -17.5% | +50.2% | +636.0% | -62.2% | -17.6% | -63.7% | +121.0% | +154.8% | -62.2% | -18.1% | +28.8% | +185.3% | +172.2% | -76.3% |
| YoY Change | — | — | — | — | +78.6% | +0.8% | >999% | +955.8% | +244.7% | +244.3% | -16.7% | -75.0% | +68.6% | -22.7% | +74.3% | +1.6% | +13.8% | +719.0% | +137.4% |
Range$800.00K – $556.10M
CAGR+57.1%
Avg YoY Growth+474.1%
Median YoY Growth+74.3%
Investment Proceeds at Other Companies
Frequently Asked Questions
- What is Eli Lilly's investment proceeds?
- Eli Lilly (LLY) reported investment proceeds of $132.00M in Q4 2025.
- How has Eli Lilly's investment proceeds changed year-over-year?
- Eli Lilly's investment proceeds increased by 137.4% year-over-year, from $55.60M to $132.00M.
- What is the long-term trend for Eli Lilly's investment proceeds?
- Over 4 years (2021 to 2025), Eli Lilly's investment proceeds has grown at a 112.4% compound annual growth rate (CAGR), from $47.40M to $964.00M.
- What does investment proceeds mean?
- Cash the company received when its investments matured or were sold.